Neurology @Point of Care Podcasts https://atpointofcare.com/our-apps/#Neurology Pinecast (https://pinecast.com) en-US@Point of Care @Point of Care atpointofcare@gmail.com no Neurology @Point of Care Podcasts https://atpointofcare.com/our-apps/#Neurology https://storage.pinecast.net/podcasts/covers/0d5b7821-5bc3-48b8-abd9-23957e3274c7/Neurology.png serial Copyright 2020 At Point of Care, LLC. All rights reserved. S1:E1 – Neurology Journal Club: Special Considerations in Parkinson’s Disease and Covid-19 https://pinecast.com/guid/86baa163-ebf3-46b4-981e-3ab6b513d20e Mon, 23 Nov 2020 17:29:03 -0000 00:41:49 http://journalclubpodcasts.com/parkinsonsdisease Visit journalclubpodcasts.com/parkinsonsdisease to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this activity, two experts discuss a paper published in the Journal of Clinical Medicine that looked at the impact of Covid-19 on patients with Parkinson’s disease—physically, emotionally, and how they are keeping up with their treatments

]]> Neurology Journal Club: Special Considerations in Parkinson’s Disease and Covid-19 no 1 1 S2:E1 – Multiple Sclerosis Morning Commute: Crystal Gazing in Multiple Sclerosis https://pinecast.com/guid/4bd4eda8-32c8-4d06-acce-c43df16c9b70 Fri, 18 Dec 2020 18:00:00 -0000 00:38:07 http://morningcommutepodcast.com/ms1

Visit http://morningcommutepodcast.com/ms1 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In our first episode – Crystal Gazing in MS, our faculty will discuss establishing the MS diagnosis, and prognostication – namely, treatment initiation timing and first line treatment selection. What forms the basis for this? How do clinicians determine an MS patient’s long-term or short-term prognosis? Does it take a crystal ball?

]]> Multiple Sclerosis Morning Commute: Crystal Gazing in Multiple Sclerosis no 2 1 S2:E2 – Multiple Sclerosis Morning Commute: Switching Tracks in MS - Timing and Direction https://pinecast.com/guid/2b7b9dbf-a544-4969-bc2e-ccc22fbd25fc Fri, 18 Dec 2020 18:05:00 -0000 00:26:27 http://morningcommutepodcast.com/ms2

Visit http://morningcommutepodcast.com/ms2 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode – Switching Tracks in MS, Timing and Direction—our faculty will discuss current perspectives on treatment escalation and lateral switches in MS patient care. They will also discuss how to assess clinical response and when a switch is warranted.

]]> Multiple Sclerosis Morning Commute: Switching Tracks in MS - Timing and Direction no 2 2 S2:E3 – Multiple Sclerosis Morning Commute: The MS Conundrum - Alike but Not Alike https://pinecast.com/guid/6f38623e-9d32-4a98-be05-ff8c441b9edb Fri, 18 Dec 2020 18:10:00 -0000 00:24:30 http://morningcommutepodcast.com/ms3

Visit http://morningcommutepodcast.com/ms3 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode – Alike, But Not Alike, our faculty will discuss how newly available diroximel fumarate (DRF) and monomethyl fumarate (MMF) compare with dimethyl fumarate (DMF). How are they alike? How do they differ? Is MMF a drug equivalent to DMF?

]]> Multiple Sclerosis Morning Commute: The MS Conundrum - Alike but Not Alike no 2 3 S2:E4 – Multiple Sclerosis Morning Commute: Close to the Mark on SPMS https://pinecast.com/guid/47773152-bf67-4723-90ed-9e9d054e6048 Fri, 18 Dec 2020 18:15:00 -0000 00:34:40 http://morningcommutepodcast.com/ms4

Visit http://morningcommutepodcast.com/ms4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will discuss the current evidence for disease-modifying therapies (DMTs) in patients with active secondary progressive MS. How is SPMS diagnosed and how does it differ from relapsing-remitting MS? Moreover, are the treatments for SPMS effective for RRMS?

]]> Multiple Sclerosis Morning Commute: Close to the Mark on SPMS no 2 4 S2:E5 – Multiple Sclerosis Morning Commute: MS Therapies - Comparing Notes on S1P Receptor Modulators https://pinecast.com/guid/acb018e1-0eb3-4e67-8c39-ce839b36de73 Fri, 18 Dec 2020 18:20:00 -0000 00:27:29 http://morningcommutepodcast.com/ms5

Visit http://morningcommutepodcast.com/ms5 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will discuss the existing and new sphingosine-1-phosphate receptor (S1PR) modulator therapies and current ongoing trials. Particularly, they will delve into what can and cannot be presumed about comparative efficacy given the absence of head-to-head trials.

]]> Multiple Sclerosis Morning Commute: MS Therapies - Comparing Notes on S1P Receptor Modulators no 2 5 S2:E6 – Multiple Sclerosis Morning Commute: What’s Next? Eyes on the Horizon https://pinecast.com/guid/60dc5306-ed59-496a-b479-8dac9e517c32 Fri, 18 Dec 2020 18:25:00 -0000 00:35:41 http://morningcommutepodcast.com/ms6

Visit http://morningcommutepodcast.com/ms6 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, our experts will discuss where we are now and what the future holds as new MS therapies emerge. For MS, has the era of true personalized medicine arrived?

]]> Multiple Sclerosis Morning Commute: What’s Next? Eyes on the Horizon no 2 6 S3:E1 – Neurology Journal Club : Special Considerations in ALS and Covid-19 https://pinecast.com/guid/48b629f9-8f83-43b5-a828-89fcf904a89a Sat, 27 Feb 2021 17:47:12 -0000 00:26:55 http://journalclubpodcasts.com/als Visit journalclubpodcasts.com/als to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this activity, two experts discuss several papers showing how the virus may affect ALS patients as well as what they are seeing in their clinics.

]]> Neurology Journal Club : Special Considerations in ALS and Covid-19 no 3 1 S4:E1 – Neurology Journal Club: Alzheimer’s Disease Biomarkers https://pinecast.com/guid/aa630ab1-db7e-4836-b48e-e9a18335390b Fri, 30 Apr 2021 15:46:00 -0000 00:26:38 http://www.morningcommutepodcast.com/ad1 Are there viable blood tests on the horizon to make diagnosis, and particularly early diagnosis, of Alzheimer’s disease possible? Our faculty takes a look at this excited field that may also enable development of better therapeutics for the disease.

Visit www.morningcommutepodcast.com/ad1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

]]> Neurology Journal Club: Alzheimer’s Disease Biomarkers no 4 1 S4:E2 – Neurology Journal Club: Emerging Treatments for Alzheimer’s Disease https://pinecast.com/guid/f6ada66f-75dc-4f05-89a3-54988ca61935 Wed, 26 May 2021 15:52:00 -0000 00:24:56 http://www.morningcommutepodcast.com/ad2 Is amyloid the right target for new Alzheimer’s disease therapies? Will any of these therapies, if they win approval, advance the treatment of Alzheimer’s disease? Our faculty explores these and other questions.

Visit www.morningcommutepodcast.com/ad2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

]]> Neurology Journal Club: Emerging Treatments for Alzheimer’s Disease no 4 2 S5:E1 – Neurology Morning Commute: New and Emerging Treatments for ALS https://pinecast.com/guid/b3b0418d-1064-4c72-b49d-aa5f2e1cb219 Thu, 15 Jul 2021 15:36:00 -0000 00:31:30 http://www.morningcommutepodcast.com/als1 In this podcast our faculty discuss new and emerging treatments for ALS, as well as managing some of the more debilitating symptoms of the disease.

Visit www.morningcommutepodcast.com/als1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

]]> Neurology Morning Commute: New and Emerging Treatments for ALS no 5 1 S6:E1 – Neurology Morning Commute: Covid-19 Vaccines and the Patient with Multiple Sclerosis https://pinecast.com/guid/cef6142c-fd1a-4706-ad2c-daf7c3e07954 Tue, 30 Nov 2021 08:30:00 -0000 00:26:50 Neurology Morning Commute: Covid-19 Vaccines and the Patient with Multiple Sclerosis no 6 1 S6:E2 – Neurology Morning Commute: Covid-19 Vaccines and Disease-Modifying Treatments for MS https://pinecast.com/guid/f83ce1b3-f7d9-491b-b22e-f8c730c1f98d Fri, 18 Mar 2022 07:30:00 -0000 Neurology Morning Commute: Covid-19 Vaccines and Disease-Modifying Treatments for MS no 6 2 S2:E7 – Neurology Morning Commute: Getting UP to Speed on Multiple Sclerosis Management https://pinecast.com/guid/5999ca48-b9da-47d8-8e77-f6e94e7ba6ae Mon, 11 Apr 2022 16:08:39 -0000 http://www.morningcommutepodcast.com/ms7 With the many treatments now available for the treatment of multiple sclerosis (MS), our faculty reviews this impressive therapeutic landscape and discusses how to choose the best ones for the individual MS patient.

Visit www.morningcommutepodcast.com/ms7 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

]]> Neurology Morning Commute: Getting UP to Speed on Multiple Sclerosis Management no 2 7 S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade https://pinecast.com/guid/2f580993-f8ce-4e73-b640-df7650a9bf87 Mon, 11 Apr 2022 16:15:00 -0000 00:23:26 In this episode, our faculty looks at the latest treatments for multiple sclerosis—the newest sphingosine-1-phosphate receptor modulators. What is their mechanism of action? Which patients would benefit from them, and how are side effects and toxicities managed with these latest treatment options?

Visit www.morningcommutepodcast.com/ms8 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

]]> Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade no 2 8 S7:E1 – Morning Commute Podcast: Drawing a Blank: When Does a Patient’s Forgetfulness Signal a Concern it Might Be Alzheimer’s Disease? https://pinecast.com/guid/0b2a453e-45f8-41aa-89c1-4ed32beb16b7 Fri, 15 Dec 2023 19:54:19 -0000 00:26:44 http://www.morningcommutepodcast.com/alzheimers1 When is a patients cognitive difficulties a signal that they may be on the road to Alzheimer's disease? Our faculty discuss some of the recent advances making this diagnosis.

Visit www.morningcommutepodcast.com/alzheimers1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

]]> Morning Commute Podcast: Drawing a Blank: When Does a Patient’s Forgetfulness Signal a Concern it Might Be Alzheimer’s Disease? no 7 1 S7:E2 – Morning Commute Podcast: Untying the Beta-Amyloid Knots in Alzheimer’s Disease https://pinecast.com/guid/7e23fa0c-76ab-463d-82e0-9c4ce32cc092 Fri, 15 Dec 2023 19:59:38 -0000 00:27:11 http://www.morningcommutepodcast.com/alzheimers2 In this podcast, our faculty discuss talk some of the newer treatments for Alzheimer's disease, especially anti-beta-amyloid antibody treatments.

Visit www.morningcommutepodcast.com/alzheimers2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

]]> Morning Commute Podcast: Untying the Beta-Amyloid Knots in Alzheimer’s Disease no 7 2 S7:E3 – Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease https://pinecast.com/guid/1c125b78-b4e6-4cc3-8cec-54aafc0f4209 Fri, 15 Dec 2023 20:01:08 -0000 00:27:42 http://www.morningcommutepodcast.com/alzheimers3 In this episode our faculty take a look at the treatment-related side effects associated with some of the newer treatments for Alzheimer’s disease, with a focus on amyloid-related imaging abnormalities (ARIA). How do you weigh the risk and benefits for your patients?

Visit www.morningcommutepodcast.com/alzheimers3 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.

]]> Morning Commute Podcast: Worth the Risk? Using Anti-Amyloid Therapies for Alzheimer’s Disease no 7 3 S8:E1 – A Deeper Look at CIDP Diagnosis and Treatment https://pinecast.com/guid/df06b57c-cd26-40cc-b39e-328f5ca4d9f2 Fri, 21 Jun 2024 16:01:00 -0000 00:26:22 https://suitehome.atpointofcare.com/library/2639.11/page/0 In this episode, A Deeper Look at CIDP Diagnosis and Treatment. Dr. Diana Castro and Dr. Jeffrey Allen discuss diagnosing CIPD with a focus on updates to the current guidelines for optimal treatment and management.   Visit https://suitehome.atpointofcare.com/library/2639.11/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

]]> A Deeper Look at CIDP Diagnosis and Treatment no 8 1 S8:E2 – Getting a Grip on CIDP https://pinecast.com/guid/77e0d80a-bb6f-4250-aca1-43ae3d769f92 Sat, 22 Jun 2024 01:04:01 -0000 00:19:12 https://suitehome.atpointofcare.com/library/2639.12/page/0 In this episode, Getting a Grip on CIDP, Dr. Diana Castro and Dr. Jeffrey Allen discuss some of the latest presentations and clinical data coming out of the 2024 American Academy of Neurology meeting.

Visit https://suitehome.atpointofcare.com/library/2639.12/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

]]> Getting a Grip on CIDP no 8 2 S9:E1 – Brain Health From Aging to Alzheimer’s Disease: Starting the Conversation https://pinecast.com/guid/61db7b4e-695f-45e2-ad33-21d008fdee48 Tue, 08 Apr 2025 01:03:42 -0000 00:27:44 https://suitehome.atpointofcare.com/library/2670.11/page/0?subdomain=alzheimers In this episode, Brain Health From Aging to Alzheimer’s Disease – Starting the Conversation, Dr. Charles Vega and Dr. Anna Chodos discuss the often difficult aspects of broaching conversations with patients about brain health and cognitive concerns. To better elucidate how clinicians can best help their patients, Debbie Casuto, a caregiver, joins them in this important discussion.   Visit podcasts.atpointofcare.com to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

This podcast is powered by Pinecast.

]]> Brain Health From Aging to Alzheimer’s Disease: Starting the Conversation no 9 1 S9:E2 – Assessing Cognitive Decline: When Should We Consider Alzheimer’s Disease? https://pinecast.com/guid/379ef511-c7be-46ae-80f4-fcaa9dcaa4ef Tue, 08 Apr 2025 01:14:09 -0000 00:22:36 https://suiteweb.atpointofcare.com/#library/alzheimers/2670.12/page/0 In this episode of Morning Commute, Dr. Charles Vega and Dr. Soo Borson tackle the challenging topics of how clinicians differentiate between normal aging and cognitive decline, and what screening tools and diagnostic strategies help arrive at a diagnosis of Alzheimer’s disease.

Visit podcasts.atpointofcare.com to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.   

This podcast is powered by Pinecast.

]]> Assessing Cognitive Decline: When Should We Consider Alzheimer’s Disease? no 9 2 S10:E1 – Accurate Diagnosis and Optimal Care of Patients With MG https://pinecast.com/guid/946732e7-c889-48f5-873f-6f0fa193d179 Thu, 31 Jul 2025 23:03:29 -0000 00:24:09 https://suiteweb.atpointofcare.com/#library/mg/2692.01/page/0 In this episode, our faculty discuss the widespread expression of human epidermal growth factor receptor 3 (HER3) across tumor types and why clinicians should have HER3 on their radar.   Visit https://suiteweb.atpointofcare.com/#library/mg/2692.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

]]> Accurate Diagnosis and Optimal Care of Patients With MG no 10 1 S10:E2 – Precision Treatment Choices to Meet the Needs of Patients with MG https://pinecast.com/guid/4833f509-5627-406e-b231-58f48059ee46 Thu, 31 Jul 2025 23:30:00 -0000 00:28:28 https://suiteweb.atpointofcare.com/#library/mg/2692.02/page/0 In this episode, Precision Treatment Choices to Meet the Needs of Patients with Myasthenia Gravis, Dr. Gil Wolfe and Dr. Shawn Bird share some of the good news that there are more options than ever before for this disease. But how can clinicians decide which of the newer targeted therapy   Visit https://suiteweb.atpointofcare.com/#library/mg/2692.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

]]> Precision Treatment Choices to Meet the Needs of Patients with MG no 10 2